摘要
目的分析住院ST段抬高型急性心肌梗死(STEMI)患者的临床特征和治疗效果,提出干预措施,以期改善患者预后。方法通过调查江西省人民医院2006、2011、2016三个特定年份STEMI住院病历,提取临床信息,分析人口学特征、临床特征、再灌注治疗、用药情况、辅助检查、住院时长及7 d天内的转归情况。结果共计江西省人民医院的997份STEMI病历纳入研究。(1)2006年、2011年和2016年患者的年龄和性别构成,差异无统计学意义(P>0.05),心血管危险因素中高血压、血脂异常、吸烟随年份的增加而增加,差异有统计学意义(P<0.05)。(2)氯吡格雷和他汀类的使用率在2006-2016年间上升幅度最大;阿司匹林、β受体阻滞剂、血管紧张素转化酶抑制剂(ACEI)或血管紧张素受体拮抗剂(ARB)、中药使用率呈较明显上升趋势。(3)2006-2016年间,住院时长并未缩短,7 d内死亡率有差异。结论 2006-2016年十年间江西省STEMI患者的危险因素明显增加,治疗药物有所调整,再灌注治疗大幅增多,患者死亡率下降。
Objective To retrospectively analyze st-elevation acute myocardial infarction(STEMI) inpatients with clinical characteristics and treatment status and put forward intervention measures. Methods The clinical information was extracted by investigating the hospital medical records in 2006,2011,2016 three specific years in Jiangxi province people's hospital. The medical records of 997 STEMI inpatients were included. Results There was no statistically significant difference in age and gender composition of patients among 2006,2011 and 2016( P > 0. 05). Cardiovascular risk factors of hypertension,dyslipidemia,smoking increased with time increase,and the difference was statistically significant( P < 0. 05). The use of clopidogrel and statin rised in 2006-2016( P < 0. 001),and the usage of aspirin,beta blockers,ACEI,ARB and the Chinese medicine increased obviously. From 2006 to 2016,the hospitalization time was not shortened,and there was no statistically significant difference. However,there were statistically significant differences in the mortality. Conclusion A risk factor for STEMI patients increased significantly in Jiangxi province during 2006-2016 decade,drugs adjusted,reperfusion treatment significantly increased,the death rates declined.
出处
《中国临床保健杂志》
CAS
2018年第1期29-33,共5页
Chinese Journal of Clinical Healthcare
基金
江西省卫生计生委科技计划项目(20165015)
关键词
心肌梗死
疾病特征
回顾性研究
Myocardial infarction
Disease Attributes
Retrospective studies
